Who
Pamela Ann Connealy
Director
Company insider
Files Form 4 as: Director, Orchestra BioMed Holdings; CFO & COO, Pyxis Oncology; Chief Financial Officer, Immunovant.
In numbers
- Trades disclosed
- 42
- Buys
- 5
- Sells
- 0
- Bought
- $230K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 18 Dec 2019
- Last trade
- 23 Jun 2026
- Last filed
- 25 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jun 2026filed 25 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —17,327 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | OBIO Orchestra BioMed Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —21,277 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | OBIO Orchestra BioMed Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —21,277 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —17,327 at $0.00 | filing |
| 7 Aug 2025filed 8 Aug 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | OBIO Orchestra BioMed Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —36,797 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —12,422 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $406K414,163 at $0.98 | filing |
| 23 Dec 2024filed 23 Dec 2024 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —310,000 at $0.00 | filing |
| 26 Nov 2024filed 27 Nov 2024 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Bought | $11K5,450 at $2.00 | filing |
| 26 Nov 2024filed 27 Nov 2024 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Bought | $163K83,400 at $1.96 | filing |
| 20 Jun 2024filed 21 Jun 2024 | OBIO Orchestra BioMed Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —17,068 at $0.00 | filing |
| 20 Jun 2024filed 21 Jun 2024 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —5,376 at $0.00 | filing |
| 26 Mar 2024filed 28 Mar 2024 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code A | —328,710 at $0.00 | filing |
| 29 Nov 2023filed 30 Nov 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code F | $52K36,949 at $1.40 | filing |
| 28 Sep 2023filed 28 Sep 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Bought | $15K8,000 at $1.87 | filing |
| 27 Sep 2023filed 27 Sep 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Bought | $12K6,426 at $1.85 | filing |
| 25 Sep 2023filed 25 Sep 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Bought | $20K12,000 at $1.67 | filing |
| 22 Sep 2023filed 22 Sep 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Bought | $8,7005,000 at $1.74 | filing |
| 7 Sep 2023filed 8 Sep 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code A | —187,793 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.